Συγγραφείς:
Kontochristopoulos, G.
Markantoni, V.
Agiasofitou, E.
Platsidaki, E.
Kouris, A.
Campanati, A.
Offidani, A.M.
Rigopoulos, D.
Gregoriou, S.
Λέξεις-κλειδιά:
glycopyrronium; lisote cream; oxybutynin; sofipironium bromide; umeclimidium; unclassified drug; mandelic acid derivative; oxybutynin, comparative effectiveness; cream; Dermatology Life Quality Index; disease severity assessment; drug approval; drug dosage form comparison; drug efficacy; drug safety; human; hyperhidrosis; Japan; Letter; protein bound iodine; quality of life; treatment withdrawal; United States; urine incontinence; axilla; hyperhidrosis; treatment outcome, Axilla; Humans; Hyperhidrosis; Mandelic Acids; Quality of Life; Treatment Outcome
